ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

Stocks have undergone a bit of a correction in recent days, brought about by renewed concerns about Europe’s debt woes and the impact China’s efforts to curb inflation will have on global trade. Ireland is facing pressure from the rest of the EU to accept aid from the European Central… Read More

We’re still waiting on Amylin Pharmaceuticals (AMLN) to break the $13.50 barrier. Once it does on a closing basis the stock could quickly climb to the $15 level before coming into any real overhead resistance. It’s a buy for new clients at its current price. Gold is undergoing a modest… Read More

As expected, the Federal Reserve announced last week its plans to move ahead with a second round of money printing, this time to the tune of $600 billion in the next six months. In effect the central bank will buy ever Treasury bond the US government offers for sale. Read More

Yesterday we closed out the Express Scripts January 21, 2011 47.50 call option for a 76 percent gain. The stock had gained more than four points in as many sessions, setting the stage for a possible near-term pullback. We also closed the Lockheed Martin December 18, 2010 (LMT) 70 call… Read More

Americans are heading to the polls today, many with the intention of registering their dissatisfaction with the economy and the job both state and federal office holders have done of fixing things. The “throw the bums out” mentality with electors is reaching across party lines, but it’s the Democrats that have the most to lose. Read More

Express Scripts (ESRX) is moving higher today compliments of rival Medco Health Solutions posting better-than-expected quarterly results. Last week management said that the company was open to purchasing another pharmacy benefit manager (PBM) “at the right price.” One possible candidate is Walgreen’s PBM business, which is known to be on… Read More